What is the prevalence of migraine headaches among adult patients attending the clinic, given that 75 out of 200 patients have migraine headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence Calculation for Migraine Headaches

The prevalence of migraine headaches among these clinic patients is 37.5% (75 out of 200 patients). This is calculated by dividing the number of patients with migraine (75) by the total number of patients assessed (200), then multiplying by 100.

Understanding the Calculation

  • Point prevalence = (Number of existing cases / Total population at risk) × 100
  • In this scenario: (75 / 200) × 100 = 37.5%

The population figure of 100,000 mentioned in the question is not relevant to calculating the prevalence among the 200 clinic patients actually assessed. Prevalence is specific to the defined population being studied—in this case, the 200 adult patients attending the clinic on that particular day.

Clinical Context of This Finding

This 37.5% prevalence is substantially higher than expected population-based estimates. According to recent U.S. data, migraine affects approximately 16% of the general adult population, with 21% of females and 11% of males affected 1. More recent surveillance data from 2015 shows a 3-month prevalence of 15.3% overall (20.7% in females, 9.7% in males) 2.

The elevated prevalence in this clinic sample (37.5% vs. 16% in the general population) likely reflects selection bias, as patients attending a clinic are more likely to have active health concerns, including migraine 3, 2.

Important Considerations

  • This represents a clinic-based sample, not a population-based estimate, which explains the higher prevalence compared to general population surveys 3, 2
  • The 3-month prevalence in the general U.S. population has remained stable over nearly two decades, ranging from 14.9% to 15.3% 3, 2
  • Migraine prevalence is highest in adults aged 18-44 years (17.9-23.5%), females, unemployed individuals, and those with household income less than $35,000 annually 1, 3, 2
  • Migraine remains underdiagnosed and undertreated, with studies showing that 82% of patients with a clinic diagnosis of "nonmigraine headache" actually had IHS-defined migraine or probable migraine when assessed longitudinally 4

Related Questions

What is the best course of action for a 58-year-old female presenting with dizziness, headache, and nausea, with a history of migraines (unilateral headache and nausea/vomiting (N/V) with vision changes), and no prior symptoms of dizziness?
What is the best course of action for a 30-year-old female with a 7-month history of progressively worsening migraines and 4-month history of joint pain, currently experiencing an intractable migraine for 5 days unresponsive to oral or intravenous (IV) medications, with worsening symptoms when bending over or laying down, and normal computed tomography (CT) scan and magnetic resonance imaging (MRI) results, despite a negative autoimmune workup?
What are the next steps for a patient with a history of migraines, currently on migraine medication, who experiences an episode of lightheadedness, tingling, and numbness all over their body?
What is the best imaging option for a post-operative adult with a history of migraines, presenting with sudden onset of right-sided chest pain, shortness of breath, tachycardia, tachypnea, hypoxia, and absent breath sounds on the right side, 1 hour after a lung biopsy?
What is the best course of action for a 30-year-old female with a 5-day intractable migraine (resistant to oral and intravenous (IV) medications) and a non-pruritic rash on her chest?
Is L4-L5 transforaminal laminectomy interbody fusion medically necessary for a female patient, post L4/5 minimally invasive surgical (MIS) discectomy, with progressive symptoms of weakness in the right leg and foot, numbness on the top of the right foot, and foot drop, despite extensive conservative management, including medication (Medrol dose pack (methylprednisolone), Methocarbamol (methocarbamol)), chiropractic treatment, and physical therapy?
What indicates a healthcare provider
What are the primary causes of appendicitis in patients of different age groups and medical histories?
What is the management and treatment approach for an older adult with pernicious anemia, likely with autoimmune predispositions?
What is the best approach to taper off Cymbalta (duloxetine) in a patient who has been on it for 10 years?
What is the treatment and management for a newborn with perinatal hypothyroidism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.